Top compounds associated with response to SLC22A13


Feature Type Standardized
Nominal ANOVA
mRNA Imatinib CTRPv2 pan-cancer AAC -0.036 0.3
mRNA semagacestat CTRPv2 pan-cancer AAC 0.037 0.3
mRNA BRD-K79669418 CTRPv2 pan-cancer AAC -0.052 0.3
mRNA Elesclomol GDSC1000 pan-cancer AAC -0.032 0.3
mRNA Erlotinib GDSC1000 pan-cancer AAC 0.046 0.3
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.035 0.3
mRNA GSK429286A GDSC1000 pan-cancer AAC -0.031 0.3
mRNA GSK461364 CTRPv2 pan-cancer AAC -0.031 0.3
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.034 0.3
mRNA HG-6-64-1 GDSC1000 pan-cancer AAC -0.032 0.3
Download CSV